UnicoCell Biomed Co., Ltd. (TPE:6794)
Taiwan · Delayed Price · Currency is TWD 82.40
+0.10 (0.12%)
At close: Jul 9, 2026
UnicoCell Biomed Market Cap
UnicoCell Biomed has a market cap or net worth of 5.24 billion as of July 9, 2026. Its market cap has increased by 35.88% in one year.
Market Cap
5.24B
Enterprise Value
4.58B
Revenue
26.54M
Ranking
n/a
PE Ratio
n/a
Stock Price
82.40
Market Cap Chart
Since December 25, 2020, UnicoCell Biomed's market cap has increased from 1.73B to 5.24B, an increase of 203.47%. That is a compound annual growth rate of 22.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 9, 2026 | 5.24B | -3.55% |
| Dec 31, 2025 | 5.44B | 36.28% |
| Dec 31, 2024 | 3.99B | -13.33% |
| Dec 29, 2023 | 4.60B | 239.58% |
| Dec 30, 2022 | 1.36B | -17.13% |
| Dec 30, 2021 | 1.64B | 1.26% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 25, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Savior Lifetec | 6.60B |
| TaiGen Biopharmaceuticals Holdings | 6.44B |
| AnnJi Pharmaceutical | 6.42B |
| Sinphar Pharmaceutical | 6.33B |
| TWi Biotechnology | 5.53B |
| Mycenax Biotech | 5.48B |
| Medigen Biotechnology | 5.33B |
| Sinew Pharma | 5.08B |